UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034184
Receipt number R000038972
Scientific Title A investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.
Date of disclosure of the study information 2018/09/20
Last modified on 2020/09/23 13:45:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.

Acronym

A investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.

Scientific Title

A investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.

Scientific Title:Acronym

A investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of temperature maintenance effect by the intake of a anthocyanin-containing juice in adult male with feeling cold.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin surface temperature

Key secondary outcomes

Peripheral blood flow


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Oral intake of a anthocyanin medium- containing juice (1 time) - washout period of week - Oral intake of a placebo juice
(1 time) - washout period of week -
Oral intake of a anthocyanin high - containing juice (1 time)

Interventions/Control_2

Oral intake of a anthocyanin high - containing juice (1 time) - washout period of week - Oral intake of a anthocyanin medium- containing juice (1 time) - washout period of week - Oral intake of a placebo juice (1 time)

Interventions/Control_3

Oral intake of a placebo juice (1 time) - washout period of week - Oral intake of a anthocyanin high- containing juice (1 time) - washout period of week - Oral intake of a anthocyanin medium - containing juice (1 time)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

(1) Healthy males more than 20 years old.
(2) Subjects who are sensitive to the cold and whose cold diagnosis questionnaire score is more than 4 points.
(3) Subjects whose recovery rate of skin temperature is less than 90% after 10 minutes of cold loading.
(4) Subjects who are obtained consent by document in free will.

Key exclusion criteria

(1)Subjects who have an allergy in connection with this study.
(2) Subjects who have been diagnosed disease with vascular disorder (e.g., arteriosclerosis obliterans, obliterating arteritis, connective tissue disease, diabetes ).
(3) Subjects who are judged as unsuitable for the study based on the results of medical questionnaire.
(4) Subjects who have smoking habit.
(5) Subjects who are regularly taking medicine (e.g., warfarin) which may influence skin surface temperature and blood flow.
(6) Subjects who are taking health food, food for specified health use which may influence skin surface temperature and blood flow more than 3 times per week (e.g., functional food which assume polyphenol derived from ginger or hesperidin as active ingredient) .
(7) Subjects who have taken anthocyanin enriched food more than 3 times per week.
(8) Subjects who are judged as unsuitable for the study based on the results of clinical examination and cardiopulmonary function.
(9) Subjects who have regular medication and a history of serious disease which needed medication treatment.
(10)Subjects who are judged as unsuitable for the study based on the results of physical and clinical examination on before intake.
(11)Subjects who have participated in
other clinical study at the start of this study.
(12)Subjects who are judged as unsuitable for the study by the investigator for other reason.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Koichi
Middle name
Last name Aizawa

Organization

Kagome Co.,Ltd

Division name

Innovation Division

Zip code

329-2762

Address

17,nishitomiyama,nasushiobara-shi,Tochigi

TEL

0287-36-2935

Email

Koichi_Aizawa@kagome.co.jp


Public contact

Name of contact person

1st name Kunihiko
Middle name
Last name Wasaki

Organization

TTC Co.,Ltd.

Division name

Clinical Research Planning Department

Zip code

150-0021

Address

1-20-2, Ebisunishi, shibuya-ku, Tokyo

TEL

0354593714

Homepage URL


Email

k.wasaki@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kagome Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kensho-kai Institutional Review Board

Address

2-12-16, Tamagawa, Fukushima-ku, Osaka

Tel

06-6882-1130

Email

ethics_board@drc-web.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 09 Month 07 Day

Date of IRB

2018 Year 09 Month 07 Day

Anticipated trial start date

2018 Year 09 Month 21 Day

Last follow-up date

2018 Year 11 Month 12 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 18 Day

Last modified on

2020 Year 09 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038972


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name